PF-06282999 (Standaard)

PF-06282999 (Standard) is the analytical standard of PF-06282999. This product is intended for research and analytical applications. PF-06282999 is a potent and selective myeloperoxidase inhibitor which is potential useful for the treatment of cardiovascular diseases.

1435467-37-0

12352100

Glutathione Peroxidase; Reference Standards

Apoptosis; Metabolic Enzyme/Protease; Others

Cardiovascular Disease

O=C(N)CN(C(C1=CC(Cl)=CC=C1OC)=C2)C(NC2=O)=S

C13H12ClN3O3S

325.77

[1]Dong JQ, et al. Pharmacokinetics and Disposition of the Thiouracil Derivative PF-06282999, an Orally Bioavailable, Irreversible Inactivator of Myeloperoxidase Enzyme, Across Animals and Humans. Drug Metab Dispos. 2016 Feb;44 (2) :209-19.|[2]Ruggeri RB, et al. Discovery of 2- (6- (5-Chloro-2-methoxyphenyl) -4-oxo-2-thioxo-3,4-dihydropyrimidin-1 (2H) -yl) acetamide (PF-06282999) : A Highly Selective Mechanism-Based Myeloperoxidase Inhibitor for the Treatment of Cardiovascular Diseases. J Med Chem. 20

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-19321R/

Reference Standards